How would a new drug corporation learn about CGMP and about FDA’s expectations on complying with them?On the higher stop in the price band, on FY 24 earnings, the stock should really trade at 26x situations which can be a fair benefit as compared with its closest peer Maruti Suzuki (29x FY 24 earnings). “For that reason, on all favourable param